Xanax maker Viatris beats quarterly estimates on demand for new generic drugs
Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.
STAT1d
Pharma’s ethically questionable sites essentially sell drugs directly to consumers
Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...
Becker's Hospital Review1d
Hims & Hers to sell generic weight loss drug in 2025
Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.
Hims & Hers to launch a generic for Novo’s older GLP-1
Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...
News Nation on MSN2d
Walgreens to pay $100M to resolve lawsuit over generic drug pricing
Walgreens was accused of wrongly requiring insured customers to pay more than members of its Prescription Savings Club.
Minnesotans may get money back in settlements with generic drugmakers over alleged price-fixing
Attorney General Keith Ellison celebrates settlements with two drug companies he accused of “scheming” to raise prices on ...
Hims & Hers Health plans to offer generic version of Novo Nordisk's diabetes drug in 2025
Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025. "We have already confirmed a core supplier ...